{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:46:23Z","timestamp":1789163183466,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejso.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T22:09:11Z","timestamp":1518732551000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience"],"prefix":"10.1016","volume":"44","author":[{"given":"Zhaohui","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy L.","family":"Hartgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal T.","family":"Sanhueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Shubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasuna","family":"Muppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Smyrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-8333","authenticated-orcid":false,"given":"Amit","family":"Mahipal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.02.008_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0039-6109(05)70142-0","article-title":"Periampullary cancers: are there differences?","volume":"81","author":"Sarmiento","year":"2001","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejso.2018.02.008_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14694\/EdBook_AM.2014.34.112","article-title":"Ampullary cancer: an overview","author":"Ahn","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2018.02.008_bib3","first-page":"A128","article-title":"Staging of ampullary carcinoma by endoscopic ultrasonography","volume":"30","author":"Palazzo","year":"1998","journal-title":"Endoscopy"},{"key":"10.1016\/j.ejso.2018.02.008_bib4","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2018.02.008_bib5","first-page":"415","article-title":"Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997\u20132002","volume":"18","author":"Goodman","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejso.2018.02.008_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":"Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program","volume":"100","author":"Albores-Saavedra","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5858\/133.1.67","article-title":"Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study","volume":"133","author":"Henson","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2018.02.008_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejso.2008.10.010","article-title":"Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology","volume":"35","author":"Morris-Stiff","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-6-126","article-title":"Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study","volume":"6","author":"Narang","year":"2011","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.02.008_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamasurg.2016.3466","article-title":"Association of histopathologic phenotype of periampullary adenocarcinomas with survival","volume":"152","author":"Williams","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11605-010-1156-4","article-title":"Lymph node involvement and not the histopathologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater","volume":"14","author":"de Paiva Haddad","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00534-007-1313-7","article-title":"Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma","volume":"15","author":"Barauskas","year":"2008","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejso.2006.10.008","article-title":"Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma","volume":"33","author":"Sakata","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/MPA.0000000000000112","article-title":"Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study","volume":"43","author":"Robert","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.ejso.2018.02.008_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.mcg.0000196191.42296.e0","article-title":"Clinicopathologic features of ampullary carcinoma without jaundice","volume":"40","author":"Kamisawa","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.ejso.2018.02.008_bib16","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s00268-008-9675-9","article-title":"Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis","volume":"32","author":"Yao","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s11605-008-0554-3","article-title":"Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio","volume":"12","author":"Smith","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejso.2015.01.010","article-title":"Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort","volume":"41","author":"Colussi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A\u00a0randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.02.008_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2018.02.008_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.ejso.2018.02.008_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"Kimura","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.ejso.2018.02.008_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.02.008_bib24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/PAS.0b013e31826399d8","article-title":"Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.02.008_bib25","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","article-title":"Survival probabilities (the Kaplan-Meier method)","volume":"317","author":"Bland","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2018.02.008_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjsurg.2008.11.010","article-title":"Does lymph node ratio impact survival in resected periampullary malignancies?","volume":"197","author":"Hurtuk","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001859","article-title":"Prognostic value of the metastatic lymph node ratio in patients with resectable carcinoma of ampulla of vater","volume":"94","author":"Hsu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejso.2018.02.008_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000658-199705000-00015","article-title":"Adenocarcinoma of the ampulla of Vater. A 28-year experience","volume":"225","author":"Talamini","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.surg.2011.05.012","article-title":"A\u00a0single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: management and outcomes","volume":"150","author":"Hornick","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2018.02.008_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejso.2011.06.008","article-title":"Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience","volume":"37","author":"Lazaryan","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib31","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11605-011-1518-6","article-title":"The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma","volume":"15","author":"Showalter","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1245\/s10434-012-2592-z","article-title":"Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas","volume":"20","author":"Pomianowska","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.02.008_bib34","first-page":"1641","article-title":"The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis","volume":"54","author":"Roh","year":"2007","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.ejso.2018.02.008_bib35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.02.008_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2006.04.018","article-title":"Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience","volume":"66","author":"Bhatia","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2018.02.008_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0360-3016(00)00537-X","article-title":"Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas","volume":"47","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2018.02.008_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archsurg.136.1.65","article-title":"Adjuvant chemoradiotherapy for \u201cunfavorable\u201d carcinoma of the ampulla of Vater: preliminary report","volume":"136","author":"Mehta","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2018.02.008_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","article-title":"Adjuvant chemo-radiotherapy in ampullary cancers","volume":"31","author":"Sikora","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.008_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2007.07.2327","article-title":"Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater","volume":"70","author":"Krishnan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2018.02.008_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2008.11.067","article-title":"Role of adjuvant chemoradiotherapy for ampulla of Vater cancer","volume":"75","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2018.02.008_bib42","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1245\/s10434-011-2117-1","article-title":"Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy","volume":"19","author":"Palta","year":"2012","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831830667X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831830667X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:25:44Z","timestamp":1760059544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879831830667X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S074879831830667X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.008","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}